𝔖 Bobbio Scriptorium
✦   LIBER   ✦

C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation

✍ Scribed by Katrin Färber; Giselle Cheung; Daniel Mitchell; Russell Wallis; Eberhard Weihe; Wilhelm Schwaeble; Helmut Kettenmann

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
332 KB
Volume
87
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Microglia, central nervous system (CNS) resident phagocytic cells, persistently police the integrity of CNS tissue and respond to any kind of damage or pathophysiological changes. These cells sense and rapidly respond to danger and inflammatory signals by changing their cell morphology; by release of cytokines, chemokines, or nitric oxide; and by changing their MHC expression profile. We have shown previously that microglial biosynthesis of the complement subcomponent C1q may serve as a reliable marker of microglial activation ranging from undetectable levels of C1q biosynthesis in resting microglia to abundant C1q expression in activated, nonramified microglia. In this study, we demonstrate that cultured microglial cells respond to extrinsic C1q with a marked intracellular Ca^2+^ increase. A shift toward proinflammatory microglial activation is indicated by the release of interleukin‐6, tumor necrosis factor‐α, and nitric oxide and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide. Our findings indicate 1) that extrinsic plasma C1q is involved in the initiation of microglial activation in the course of CNS diseases with blood–brain barrier impairment and 2) that C1q synthesized and released by activated microglia is likely to contribute in an autocrine/paracrine way to maintain and balance microglial activation in the diseased CNS tissue. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Activation of the classical pathway of c
Activation of the classical pathway of complement by rheumatoid factors
✍ Umesh K. Sabharwal; John H. Vaughan; Sherman Fong; Peter H. Bennett; Dennis A. C 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 667 KB

## Abstract A simple, sensitive solid‐phase radioimmunoassay to quantitate the activation of the classical pathway of complement by rheumatoid factor (RF) is described. RF (purified, in serum or synovial fluid) was bound to reduced and alkylated IgG adsorbed to polyvinyl chloride microtiter plates

The complement subcomponent C1q mediates
The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro
✍ Mohamed R. Daha; André M. M. Miltenburg; Pieter S. Hiemstra; Ngaisah Klar-Mohama 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

## The complement subcomponent Clq mediates binding of immune complexes and aggregates to endothelial cells in vitro* The present studies were initiated to investigate whether soluble immune complexes, upon interaction with complement, can bind to endothelial cells. Human umbilical vein endothelia

Intact B cell tolerance in the absence o
Intact B cell tolerance in the absence of the first component of the classical complement pathway
✍ Antony J. Cutler; Richard J. Cornall; Helen Ferry; Anthony P. Manderson; Marina 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

A critical role for complement in the regulation of self tolerance has been proposed to explain the strong association between complement deficiency and autoimmunity. To elucidate the role of the classical pathway of complement in the maintenance of B cell tolerance, C1qdeficient (C1qa-/-) mice were